• Mon. Apr 15th, 2024

President Biden Tackles High Drug Costs: The Need for Affordable Health Care for All Americans

BySamantha Jones

Apr 3, 2024
Biden talks about limiting certain drug prices

President Biden has addressed the issue of high drug costs in the United States during a recent discussion, highlighting that some actions by pharmaceutical companies amount to exploitation. Three companies have agreed to cap the price of asthma inhalers at $35, providing relief to Americans who rely on these medications. Meanwhile, Senator Bernie Sanders, an independent from Vermont, has also emphasized the need to tackle the high cost of prescription drugs and commended the efforts of the Biden administration and Democrats in Congress to push for lower drug prices.

The ongoing efforts to address high drug costs and make health care more affordable for Americans are crucial priorities for the Biden administration and lawmakers in Congress. Data from the Kaiser Family Foundation showed that the average annual health care premium for single coverage in 2023 was $8,435, while family coverage averaged $23,968. Premiums have increased by 22% for both types of coverage since 2018. This increase is especially concerning as it affects millions of Americans who rely on employer-sponsored plans or purchase insurance through state-based marketplaces established by the Affordable Care Act (ACA), commonly known as Obamacare.

During the most recent Open Enrollment Period, more than 21 million Americans either selected or were automatically re-enrolled in health insurance coverage through HealthCare.gov and state-based Marketplaces. While this is a significant achievement, it is not enough to address the root causes of high drug costs and rising health care premiums. It is essential that lawmakers continue to push for policies that prioritize affordability and accessibility in healthcare for all Americans.

In conclusion, addressing high drug costs and making healthcare more affordable remains a critical priority for President Biden and lawmakers in Congress. The three companies agreeing to cap asthma inhaler prices at $35 is a positive step towards ensuring that Americans have access to necessary medication at an affordable price. However, there is still much work to be done in order to reduce healthcare costs overall and ensure that all Americans can access quality healthcare regardless of their financial situation or location.

By Samantha Jones

As a content writer at newsnnk.com, I weave words into captivating stories that inform and engage our readers. With a passion for storytelling and an eye for detail, I strive to deliver high-quality and engaging content that resonates with our audience. From breaking news to thought-provoking features, I am dedicated to providing informative and compelling articles that keep our readers informed and entertained. Join me on this journey as we explore the world through the power of words.

Leave a Reply